US National TOP Registry
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: OCS Lung.
- Who it may be relevant to
- Registry conditions: Lung Transplant. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
US National OCS Lung Thoracic Organ Perfusion (TOP) Registry
Overview
The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.
Interventions
- Device OCS Lung
The TransMedics Organ Care System (OCS) Lung is an FDA approved portable extracorporeal lung perfusion and monitoring system.
Primary outcome measures
- One-year patient and graft survival [Time frame: 1-year post-transplant]
Eligibility criteria
All lung transplant recipients
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
United States · 7 centers
- St. Joseph's Hospital & Medical Center — Phoenix
- Stanford University School of Medicine — Stanford
- University of Minnesota — Minneapolis
- Duke University — Durham
- Baylor Scott & White Research Institute — Dallas
- Baylor College of Medicine — Houston
- Medical College of Wisconsin — Milwaukee
Identifiers
NCT: NCT06513091 · OCS-LUN-TOP-II